2023


  1. Helmert C, Fleischer T, Speerforck S, Ulke C, Altweck L, Hahm S, Muehlan H, Schmidt S, Grabe HJ, Völzke H, Schomerus G (2023). An explorative cross-sectional analysis of mental health shame and help-seeking intentions in different lifestyles. Sci Rep, 13, 10825.
     
  2. Widmer M, Schmidt-Recla A, Steinberg H (2023). [Forensic Psychiatry in the GDR: An overview]. Fortschr Neurol Psychiatr, 91, 199-208.
     
  3. Otten D, Heller A, Schmidt P, Beutel ME, Brähler E (2023). Gender differences in the prevalence of mental distress in East and West Germany over time: a hierarchical age-period-cohort analysis, 2006-2021. Soc Psychiatry Psychiatr Epidemiol, 0, 0-0.
     
  4. McLaren T, Peter LJ, Tomczyk S, Muehlan H, Schomerus G, Schmidt S (2023). The Seeking Mental Health Care model: prediction of help-seeking for depressive symptoms by stigma and mental illness representations. BMC Public Health, 23, 69.
     
  5. Peter LJ, McLaren T, Tomczyk S, Mühlan H, Schmidt S, Schomerus G (2023). Determinanten der Inanspruchnahme psychischer Gesundheitsversorgung ? ein integratives Modell Public Health Forum, 31, 223-226.
     
  6. Helmert C, Speerforck S, Fleischer T, Otten D, Kasinger C, Brähler E, Muehlan H, Altweck L, Hahm S, Schmidt S, Reusche M, Glaesmer H, Hinz A, Reyes N, Wirkner K, Engel C, Schomerus G, Ulke C (2023). Explorative analyses on spatial differences in the desire for social distance toward people with mental illness in a diverging city. Front Public Health, 11, 1260118.
     
  7. McLaren T, Peter LJ, Tomczyk S, Muehlan H, Schomerus G, Schmidt S (2023). The Seeking Mental Health Care model: prediction of help-seeking for depressive symptoms by stigma and mental illness representations. BMC Public Health, 23, 69.
     
  8. Greffin K, Muehlan H, van den Berg N, Hoffmann W, Ritter O, Oeff M, Speerfork S, Schomerus G, Schmidt S (2023). Measuring context that matters: validation of the modular Tele-QoL patient-reported outcome and experience measure. Qual Life Res, 0, 0-0.
     
  9. Tomczyk S, Heineck S, McLaren T, Peter LJ, Schomerus G, Schmidt S, Muehlan H (2023). Yes, I can! Development and validation of the self-efficacy for self-help scale. J Affect Disord, 331, 279-286.
     
  10. Hahm S, Altweck L, Franz H, Schmidt S, Fleischer T, Helmert C, Ulke C, Speerforck S, Schomerus G, Klinger-König J, Grabe HJ, Beutel ME, Brähler E, Muehlan H (2023). [Life events related to the German reunification and their associations with psychosocial health in a sample of northeast Germany]. Z Psychosom Med Psychother, 69, 218-234.
     
  11. Krakau L, Leuzinger-Bohleber M, Brähler E, Schmidt P, Rost F, Huber D, Klug G, Löffler-Stastka H, Rössler-Schülein H, Leichsenring F, Salzer S, Brockmann J, Jakobsen T, Ernst M, Beutel ME (2023). Efficacy of high-intensity versus low-intensity psychoanalytically oriented long-term treatments and determinants of outcome: individual participant data Meta-analysis of Long-term Analytic treatment Studies (MeLAS). BMJ Open, 13, 069332.
     
  12. Heller A, Braunheim L, Decker O, Brähler E, Schmidt P (2023). Is the migrant share really the problem? Size of migrant population and individual authoritarianism as major determinants of xenophobic attitudes Ethnic and Racial Studies, 0, 0-0.
     
  13. McLaren T, Peter LJ, Tomczyk S, Muehlan H, Schomerus G, Schmidt S (2023). The effects of causal and self-efficacy beliefs on help-seeking for people with depressive complaints: a quasi-experimental online study. Front Psychiatry, 14, 1232848.
     


    14. 2022


  14. Widmer M, Schmidt-Recla A, Steinberg H (2022). [Forensic Psychiatry in the GDR: An overview]. Fortschr Neurol Psychiatr, 0, 0-0.
     
  15. Kilian C, O'Donnell A, Potapova N, López-Pelayo H, Schulte B, Miquel L, Paniello Castillo B, Schmidt CS, Gual A, Rehm J, Manthey J (2022). Changes in alcohol use during the COVID-19 pandemic in Europe: A meta-analysis of observational studies. Drug Alcohol Rev, 0, 0-0.
     
  16. Kilian C, O'Donnell A, Potapova N, López-Pelayo H, Schulte B, Miquel L, Paniello Castillo B, Schmidt CS, Gual A, Rehm J, Manthey J (2022). Changes in alcohol use during the COVID-19 pandemic in Europe: A meta-analysis of observational studies. Drug Alcohol Rev, 41(4), 918-931.
     
  17. Schmidt H, Koschinowski J, Bischof G, Schomerus G, Borgwardt S, Rumpf HJ (2022). [Attitudes of Medical Students Towards Alcohol-Related Disorders: Dependent on Intended Medical Specialization?] Psychiatr Prax, 0, 0-0.
     
  18. Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Verde PE, Correll CU, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl TB, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Leucht S, Cordes J (2022). Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial. Lancet Psychiatry, 9, 291-306.
     
  19. Tomczyk S, Schlick S, Gansler T, McLaren T, Muehlan H, Peter LJ, Schomerus G, Schmidt S (2022). Continuum beliefs of mental illness: a systematic review of measures. Soc Psychiatry Psychiatr Epidemiol, 0, 1-16.
     
  20. Khachatryan K, Beutel ME, Stöbel-Richter Y, Zenger M, Berth H, Brähler E, Schmidt P (2022). Are Attitudes towards COVID-19 Pandemic Related to Subjective Physical and Mental Health? Int J Environ Res Public Health, 19, 14538.
     
  21. Heller A, Decker O, Clemens V, Fegert JM, Heiner S, Brähler E, Schmidt P (2022). Changes in authoritarianism before and during the COVID-19 pandemic: Comparisons of latent means across East and West Germany, gender, age, and education. Front Psychol, 13, 941466.
     


    22. 2021


  22. Ulke C, Gfesser T, Fleischer T, Altweck L, Hahm S, Mühlan H, Heller A, Beutel ME, Schmidt S, Grabe HJ, Schomerus G, Brähler E, Speerforck (2021). Later-life depressive symptoms and anxiety attacks in displaced and nondisplaced populations Journal of Affective Disorders Reports, 3, 0-0.
     
  23. Peter LJ, Schindler S, Sander C, Schmidt S, Muehlan H, McLaren T, Tomczyk S, Speerforck S, Schomerus G (2021). Continuum beliefs and mental illness stigma: a systematic review and meta-analysis of correlation and intervention studies. Psychol Med, 51, 716-726.
     
  24. Dogan-Sander E, Mergl R, Willenberg A, Baber R, Wirkner K, Riedel-Heller SG, Röhr S, Schmidt FM, Schomerus G, Sander C (2021). Inflammation and the Association of Vitamin D and Depressive Symptomatology. Nutrients, 13, 1972.
     
  25. Kilian C, Manthey J, Carr S, Hanschmidt F, Rehm J, Speerforck S, Schomerus G (2021). Stigmatization of people with alcohol use disorders: An updated systematic review of population studies. Alcohol Clin Exp Res, 45, 899-911.
     
  26. Ulke C, Fleischer T, Muehlan H, Altweck L, Hahm S, Glaesmer H, Fegert JM, Zenger M, Grabe HJ, Schmidt S, Beutel ME, Schomerus G, Brähler E, Speerforck S (2021). Socio-political context as determinant of childhood maltreatment: a population-based study among women and men in East and West Germany. Epidemiology and Psychiatric Sciences, 30, 1-8.
     
  27. Tibubos AN, Otten D, Zöller D, Binder H, Wild PS, Fleischer T, Johar H, Atasoy S, Schulze L, Ladwig KH, Schomerus G, Linkohr B, Grabe HJ, Kruse J, Schmidt CO, Münzel T, König J, Brähler E, Beutel ME (2021). Bidimensional structure and measurement equivalence of the Patient Health Questionnaire-9: sex-sensitive assessment of depressive symptoms in three representative German cohort studies. BMC Psychiatry, 21, 238.
     
  28. Altweck L, Hahm S, Muehlan H, Gfesser T, Ulke C, Speerforck S, Schomerus G, Beutel ME, Brähler E, Schmidt S (2021). The interplay of gender, social context, and long-term unemployment effects on subjective health trajectories. BMC Public Health, 21, 290.
     
  29. Surova G, Ulke C, Schmidt FM, Hensch T, Sander C, Hegerl U (2021). Fatigue and brain arousal in patients with major depressive disorder. Eur Arch Psychiatry Clin Neurosci, 271, 527-536.
     
  30. Greffin K, Muehlan H, van den Berg N, Hoffmann W, Ritter O, Oeff M, Schomerus G, Schmidt S (2021). Setting-Sensitive Conceptualization and Assessment of Quality of Life in Telemedical Care-Study Protocol of the Tele-QoL Project. Int J Environ Res Public Health, 18, 10454.
     
  31. Greffin K, Schmidt S, van den Berg N, Hoffmann W, Ritter O, Oeff M, Schomerus G, Muehlan H (2021). Same same-but different: using qualitative studies to inform concept elicitation for quality of life assessment in telemedical care: a request for an extended working model. Health Qual Life Outcomes, 19, 175.
     
  32. O'Donnell A, Schulte B, Manthey J, Schmidt CS, Piazza M, Chavez IB, Natera G, Aguilar NB, Hernández GYS, Mejía-Trujillo J, Pérez-Gómez A, Gual A, de Vries H, Solovei A, Kokole D, Kaner E, Kilian C, Rehm J, Anderson P, Jané-Llopis E (2021). Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America. PLoS One, 16, 0255594.
     
  33. Anderson P, Manthey J, Llopis EJ, Rey GN, Bustamante IV, Piazza M, Aguilar PSM, Mejía-Trujillo J, Pérez-Gómez A, Rowlands G, Lopez-Pelayo H, Mercken L, Kokole D, O'Donnell A, Solovei A, Kaner E, Schulte B, de Vries H, Schmidt C, Gual A, Rehm J (2021). Impact of Training and Municipal Support on Primary Health Care-Based Measurement of Alcohol Consumption in Three Latin American Countries: 5-Month Outcome Results of the Quasi-experimental Randomized SCALA Trial. J Gen Intern Med, 36, 2663-2671.
     
  34. Kilian C, Manthey J, Carr S, Hanschmidt F, Rehm J, Speerforck S, Schomerus G (2021). Stigmatization of people with alcohol use disorders: An updated systematic review of population studies. Alcohol Clin Exp Res, 45, 899-911.
     
  35. McLaren T, Peter LJ, Tomczyk S, Muehlan H, Stolzenburg S, Schomerus G, Schmidt S (2021). How can the utilisation of help for mental disorders be improved? A quasi-experimental online study on the changeability of stigmatising attitudes and intermediate variables in the process of utilisation. BMC Public Health, 21(1), 2124.
     
  36. McLaren T, Peter LJ, Tomczyk S, Muehlan H, Stolzenburg S, Schomerus G, Schmidt S (2021). How can the utilisation of help for mental disorders be improved? A quasi-experimental online study on the changeability of stigmatising attitudes and intermediate variables in the process of utilisation. BMC Public Health, 21, 2124.
     


    37. 2020


  37. Tomczyk S, Schmidt S, Muehlan H, Stolzenburg S, Schomerus G (2020). A Prospective Study on Structural and Attitudinal Barriers to Professional Help-Seeking for Currently Untreated Mental Health Problems in the Community. J Behav Health Serv Res, 47, 54-69.
     
  38. Schmidt FM, Mergl R, Minkwitz J, Holdt LM, Teupser D, Hegerl U, Himmerich H, Sander C (2020). Is There an Association or Not?-Investigating the Association of Depressiveness, Physical Activity, Body Composition and Sleep With Mediators of Inflammation. Front Psychiatry, 11, 563.
     
  39. Tomczyk S, Schomerus G, Stolzenburg S, Muehlan H, Schmidt S (2020). Ready, Willing and Able? An Investigation of the Theory of Planned Behaviour in Help-Seeking for a Community Sample with Current Untreated Depressive Symptoms. Prev Sci, 21, 749-760.
     
  40. Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Wobrock T, Cordes J (2020). A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design. Eur Arch Psychiatry Clin Neurosci, 270, 83-94.
     
  41. Otte C, Chae WR, Nowacki J, Kaczmarczyk M, Piber D, Roepke S, Märschenz S, Lischewski S, Schmidt S, Ettrich B, Grabe HJ, Hegerl U, Hinkelmann K, Hofmann T, Janowitz D, Junghanns K, Kahl KG, Klein JP, Krueger THC, Leicht G, Prvulovic D, Reif A, Schoettle D, Strauß M, Westermair A, Friede T, Gold SM (2020). Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open, 10, 040119.
     
  42. Minkwitz J, Sander C, Himmerich H, Thormann J, Chittka T, Hegerl U, Schmidt F, Murray M, Albayrak N, Campbell IC, Scheipl F (2020). Reported and Recorded Sleepiness in Obesity and Depression. Front Psychiatry, 11, 200.
     
  43. Surova G, Ulke C, Schmidt FM, Hensch T, Sander C, Hegerl U (2020). Fatigue and brain arousal in patients with major depressive disorder. Eur Arch Psychiatry Clin Neurosci, 0, 0-0.
     


    44. 2019


  44. Schindler S, Schmidt L, Stroske M, Storch M, Anwander A, Trampel R, Strauss M, Hegerl U, Geyer S, Schonknecht P (2019). Hypothalamus enlargement in mood disorders. Acta Psychiatr Scand, 139(1), 56-67.
     
  45. Hartmann R, Schmidt FM, Sander C, Hegerl U (2019). Heart Rate Variability as Indicator of Clinical State in Depression. Front Psychiatry, 9, 735.
     
  46. Horsfield P, Stolzenburg S, Hahm S, Tomczyk S, Muehlan H, Schmidt S, Schomerus G (2019). Self-labeling as having a mental or physical illness: the effects of stigma and implications for help-seeking. Soc Psychiatry Psychiatr Epidemiol, 0, 0.
     
  47. Tomczyk S, Schmidt S, Muehlan H, Stolzenburg S, Schomerus G (2019). A Prospective Study on Structural and Attitudinal Barriers to Professional Help-Seeking for Currently Untreated Mental Health Problems in the Community. J Behav Health Serv Res, 0, 0.
     
  48. Schmidt FM, Koch J, Nowak C, Holdt LM, Teupser D, Hegerl U, Himmerich H (2019). Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy. J Psychiatr Res, 119, 116-121.
     
  49. Schmidt FM, Sander C, Walter M (2019). Editorial: Recent Advances on the Multimodal Search for Markers of Treatment Response in Affective Disorders: From Bench to Bedside? Front Psychiatry, 10, 790.
     
  50. Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-Mayfrank E, Grunder G, Hasan A, Brockhaus-Dumke A, Jager M, Baumgartner J, Wobrock T, Cordes J (2019). A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design. Eur Arch Psychiatry Clin Neurosci, 0, 0.
     


    51. 2018


  51. Schmidt FM, Sander C, Minkwitz J, Mergl R, Dalton B, Holdt LM, Teupser D, Hegerl U, Himmerich H (2018). Serum Markers of Inflammation Mediate the Positive Association Between Neuroticism and Depression. Front Psychiatry, 9, 609.
     
  52. Schindler S, Schmidt L, Stroske M, Storch M, Anwander A, Trampel R, Strauß M, Hegerl U, Geyer S, Schönknecht P (2018). Hypothalamus enlargement in mood disorders. Acta Psychiatr Scand, 0, 0.
     
  53. Sander C, Schmidt JM, Mergl R, Schmidt FM, Hegerl U (2018). Changes in brain arousal (EEG-vigilance) after therapeutic sleep deprivation in depressive patients and healthy controls. Sci Rep, 8, 15087.
     
  54. Schmidt FM (2018). Cognitive behaviour therapy and inflammation: A systematic review of its relationship and the potential implications for the treatment of depression. Aust N Z J Psychiatry, 52, 385-386.
     


    55. 2017


  55. Schmidt FM, Schindler S, Adamidis M, Strauss M, Trankner A, Trampel R, Walter M, Hegerl U, Turner R, Geyer S, Schonknecht P (2017). Habenula volume increases with disease severity in unmedicated major depressive disorder as revealed by 7T MRI. Eur Arch Psychiatry Clin Neurosci, 267(2), 107-115.
     
  56. Schmidt FM, Sander C, Dietz ME, Nowak C, Schroder T, Mergl R, Schonknecht P, Himmerich H, Hegerl U (2017). Brain arousal regulation as response predictor for antidepressant therapy in major depression. Sci Rep, 7, 45187.
     


    57. 2016


  57. Schmidt FM, Pschiebl A, Sander C, Kirkby KC, Thormann J, Minkwitz J, Chittka T, Weschenfelder J, Holdt LM, Teupser D, Hegerl U, Himmerich H (2016). Impact of Serum Cytokine Levels on EEG-Measured Arousal Regulation in Patients with Major Depressive Disorder and Healthy Controls. Neuropsychobiology, 73(1), 1-9.
     
  58. Schmidt FM, Schröder T, Kirkby KC, Sander C, Suslow T, Holdt LM, Teupser D, Hegerl U, Himmerich H (2016). Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression. Psychiatry Res, 239, 85-91.
     
  59. Schmidt R, Steinberg H (2016). [Müller-Hegemanns classification of depressions of 1964 as a proposal for a conceptualization of affective disorders: A critical review]. Fortschr Neurol Psychiatr, 84(6), 344-353.
     
  60. Schmidt FM, Kirkby KC, Lichtblau N (2016). Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. Review. Curr Neuropharmacol, 14(7), 674-687.
     
  61. Buron P, Jimenez-Trevino L, Saiz PA, Garcia-Portilla MP, Corcoran P, Carli V, Fekete S, Hadlaczky G, Hegerl U, Michel K, Sarchiapone M, Temnik S, Varnick A, Verbanck P, Wasserman D, Schmidtke A, Bobes (2016). Reasons for Attempted Suicide in Europe: Prevalence, Associated Factors, and Risk of Repetition. Arch Suicide Res, 20(1), 45-58.
     
  62. Koppara A, Wolfsgruber S, Kleineidam L, Schmidtke K, Frolich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hull M, Gertz HJ, Schroder J, Pantel J, Rienhoff O, Ru (2016). The Latent Dementia Phenotype ? is Associated with Cerebrospinal Fluid Biomarkers of Alzheimers Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment. J Alzheimers Dis, 49(2), 547-560.
     


    63. 2015


  63. Petersein C, Sack U, Mergl R, Schönherr J, Schmidt FM, Lichtblau N, Kirkby KC, Bauer K, Himmerich H (2015). Impact of lithium alone and in combination with antidepressants on cytokine production in vitro. J Neural Transm, 122(1), 109-122.
     
  64. Schmidt FM, Nowak C, Kratzsch J, Sander C, Hegerl U, Schönknecht P (2015). Dynamics of melanin-concentrating hormone (MCH) serum levels in major depressive disorder during antidepressant treatment. J Affect Disord, 180, 207-213.
     
  65. Schmidt FM, Weschenfelder J, Sander C, Minkwitz J, Thormann J, Chittka T, Mergl R, Kirkby KC, Fasshauer M, Stumvoll M, Holdt LM, Teupser D, Hegerl U, Himmerich H (2015). Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One, 10(3), e0121971.
     
  66. Schmidt FM, Steinberg H, Himmerich H (2015). [Differential diagnosis of bipolar disorder: historical and clinical implications and perspectives]. Fortschr Neurol Psychiatr, 83(2), 74-82.
     
  67. Schmidt FM, Mergl R, Stach B, Jahn I, Schonknecht P (2015). Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder. World J Biol Psychiatry, 16(2), 106-113.
     
  68. Jawinski P, Sander C, Mauche N, Spada J, Huang J, Schmidt A, Hantzsch M, Burkhardt R, Scholz M, Hegerl U, Hensch T (2015). Brain Arousal Regulation in Carriers of Bipolar Disorder Risk Alleles. Neuropsychobiology, 72(2), 65-73.
     
  69. Mergl R, Koburger N, Heinrichs K, Szekely A, Toth MD, Coyne J, Quintao S, Arensman E, Coffey C, Maxwell M, Varnik A, van Audenhove C, McDaid D, Sarchiapone M, Schmidtke A, Genz A, Gusmao R, Hegerl U (2015). What Are Reasons for the Large Gender Differences in the Lethality of Suicidal Acts? An Epidemiological Analysis in Four European Countries. PLoS One, 10(7), e0129062.
     
  70. Wolfsgruber S, Jessen F, Koppara A, Kleineidam L, Schmidtke K, Frolich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hull M, Gertz HJ, Schroder J, Pantel J, Rien (2015). Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI. Neurology, 84(12), 1261-1268.
     
  71. Koppara A, Wolfsgruber S, Kleineidam L, Schmidtke K, Frolich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hull M, Gertz HJ, Schroder J, Pantel J, Rienhoff O, Ru (2015). The Latent Dementia Phenotype ? is Associated with Cerebrospinal Fluid Biomarkers of Alzheimers Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment. J Alzheimers Dis, 49(2), 547-560.
     


    72. 2014


  72. Schmidt FM, Lichtblau N, Minkwitz J, Chittka T, Thormann J, Kirkby KC, Sander C, Mergl R, Fasshauer M, Stumvoll M, Holdt LM, Teupser D, Hegerl U, Himmerich H (2014). Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J Psychiatr Res, 55, 29-34.
     
  73. Schmidt FM, Mergl R, Stach B, Jahn I, Gertz HJ, Schonknecht P (2014). Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimers disease. Neurosci Lett, 570, 81-85.
     
  74. Schmidt FM, Kirkby KC, Himmerich H (2014). The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases. Psychiatr Danub, 26(3), 288-290.
     
  75. Maloney J, Pfuhlmann B, Arensman E, Coffey C, Gusmao R, Postuvan V, Scheerder G, Sisask M, van der Feltz-Cornelis CM, Hegerl U, Schmidtke A (2014). How to adjust media recommendations on reporting suicidal behavior to new media developments. Arch Suicide Res, 18(2), 156-169.
     
  76. Carli V, Mandelli L, Zaninotto L, Iosue M, Hadlaczky G, Wasserman D, Hegerl U, Varnik A, Reisch T, Pfuhlmann B, Maloney J, Schmidtke A, Serretti A, Sarchiapone M (2014). Serious suicidal behaviors: socio-demographic and clinical features in a multinational, multicenter sample. Nord J Psychiatry, 68(1), 44-52.
     


    77. 2013


  77. Schmidt FM, Lichtblau N, Uribe MM, Kirchherr H, Himmerich H (2013). Agomelatine in breast milk. Int J Neuropsychopharmacol, 16(2), 497-499.
     
  78. Schmidt FM, Schonherr J, Sander C, Kirkby KC, Hegerl U, Himmerich H (2013). Applying EEG-based vigilance measurement in a case of adult attention deficit hyperactivity disorder. Int J Neuropsychopharmacol, 16(5), 1169-71.
     
  79. Gertz HJ, Stoppe G, Muller-Oerlinghausen B, Schmidt LG, Baethge C, Hiemke C, Lieb K, Bschor T (2013). [Antipsychotics for treatment of neuropsychiatric disorders in dementia.] Nervenarzt, 84(3), 370-3.
     
  80. Schmidt FM, Kratzsch J, Gertz HJ, Tittmann M, Jahn I, Pietsch UC, Kaisers UX, Thiery J, Hegerl U, Schönknecht P (2013). Correction: Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer's Disease. PLoS One, 8(6), e63136.
     
  81. Schindler S, Schönknecht P, Schmidt L, Anwander A, Strauss M, Trampel R, Bazin PL, Moller HE, Hegerl U, Turner R, Geyer S (2013). Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-tesla magnetic resonance images. PLoS One, 8(7), e66394.
     
  82. Kluge M, Schmidt D, Uhr M, Steiger A (2013). Ghrelin suppresses nocturnal secretion of luteinizing hormone (LH) and thyroid stimulating hormone (TSH) in patients with major depression. J Psychiatr Res, 47(9), 1236-1239.
     
  83. Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H (2013). Cytokines as biomarkers in depressive disorder: current standing and prospects. Int Rev Psychiatry, 25(5), 592-603.
     
  84. Schmidt L, Ceglarek U, Kortz L, Hoop M, Kirkby KC, Thiery J, Himmerich H (2013). Mechanisms of Involvement of Eicosanoids and their Precursors in the Pathophysiology and Treatment of Schizophrenia. Med Chem, 9(6), 763-773.
     
  85. Anderson-Schmidt H, Adler L, Aly C, Anghelescu IG, Bauer M, Baumgartner J, Becker J, Bianco R, Becker T, Bitter C, Bonsch D, Buckow K, Budde M, Buhrig M, Deckert J, Demiroglu SY, Dietrich D, Dumpelman (2013). The "DGPPN-Cohort": a national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients. Eur Arch Psychiatry Clin Neurosci, 263(8), 695-701.
     


    86. 2012


  86. Cibis A, Mergl R, Bramesfeld A, Althaus D, Niklewski G, Schmidtke A, Hegerl U (2012). Preference of lethal methods is not the only cause for higher suicide rates in males. J Affect Disord, 136(1-2), 9-16.
     
  87. Schmidt FM, Tennert C, Teupser D, Himmerich H (2012). [Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression]. Psychiatr Prax, 39(5), 239-242.
     
  88. Himmerich H, Schmidt L, Becker S, Kortz L, Schonherr J, Mergl R, Bauer K, Sack U, Sheldrick AJ, Thiery J, Ceglarek U (2012). Impact of clozapine, N-desmethylclozapine and chlorpromazine on thromboxane production in vitro. Med Chem, 8(6), 1032-1038.
     
  89. Lichtblau N, Schmidt FM, Himmerich H (2012). Immunsystem und Depression. Die Rolle von Zytokinen bei der Depression. InFo Neurologie & Psychiatrie, 9, 60-68.
     
  90. Kluge M, Schussler P, Schmidt D, Uhr M, Steiger A (2012). Ghrelin suppresses secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in women. J Clin Endocrinol Metab, 97(3), E448-451.
     
  91. Peters O, Lorenz D, Fesche A, Schmidtke K, Hull M, Perneczky R, Ruther E, Moller HJ, Jessen F, Maier W, Kornhuber J, Jahn H, Luckhaus C, Gertz HJ, Schroder J, Pantel J, Teipel S, Wellek S, Frolich L, (2012). A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. J Nutr Health Aging, 16(6), 544-548.
     
  92. Kern N, Sheldrick AJ, Schmidt FM, Minkwitz J (2012). Neurobiology of depression and novel antidepressant drug targets. Curr Pharm Des, 18(36), 5791-5801.
     


    93. 2011


  93. Kluge M, Schussler P, Dresler M, Schmidt D, Yassouridis A, Uhr M, Steiger A (2011). Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression. J Psychiatr Res, 45(3), 421-426.
     
  94. Mergl R, Havers I, Althaus D, Rihmer Z, Schmidtke A, Lehfeld H, Niklewski G, Hegerl U (2011). Geschlechtsunterschiede in der Saisonalität von Suizidversuchen. Suizidprophylaxe, 38(1), 143-151.
     
  95. Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauss M, Baum P, Hegerl U, Schonknecht P (2011). CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Res, 190(2-3), 240-243.
     
  96. Schmidt FM, Kratzsch J, Hegerl U, Schönknecht P (2011). Die Rolle der Hypocretine bei affektiven Störungen. Nervenheilkunde, 30(11), 893-897.
     


    97. 2010


  97. Hegerl U, Mergl R, Havers I, Schmidtke A, Lehfeld H, Niklewski G, Althaus D (2010). Sustainable effects on suicidality were found for the Nuremberg alliance against depression. Eur Arch Psychiatry Clin Neurosci, 260(5), 401-406.
     
  98. Mergl R, Havers I, Althaus D, Rihmer Z, Schmidtke A, Lehfeld H, Niklewski G, Hegerl U (2010). Seasonality of suicide attempts: association with gender. Eur Arch Psychiatry Clin Neurosci, 260(5), 393-400.
     
  99. Schmidt FM, Brugel M, Kratzsch J, Strauss M, Sander C, Baum P, Thiery J, Hegerl U, Schonknecht P (2010). Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neurosci Lett, 483(1), 20-22.
     
  100. Lewczuk P, Kornhuber J, Vanmechelen E, Peters O, Heuser I, Maier W, Jessen F, Burger K, Hampel H, Frolich L, Henn F, Falkai P, Ruther E, Jahn H, Luckhaus Ch, Perneczky R, Schmidtke K, Schroder J, Kess (2010). Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Exp Neurol, 223(2), 366-370.
     
  101. Teipel SJ, Ewers M, Wolf S, Jessen F, Kolsch H, Arlt S, Luckhaus C, Schonknecht P, Schmidtke K, Heuser I, Frolich L, Ende G, Pantel J, Wiltfang J, Rakebrandt F, Peters O, Born C, Kornhuber J, Hampel H (2010). Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res, 182(3), 244-250.
     
  102. Preuss UW, Zetzsche T, Pogarell O, Mulert C, Frodl T, Müller D, Schmidt G, Born C, Reiser M, Möller HJ, Hegerl U, Meisenzahl EM (2010). Anterior cingulum volumetry, auditory P300 in schizophrenia with negative symptoms. Psychiatry Res, 183(2), 133-139.
     


    103. 2009


  103. Värnik A, Kolves K, Allik J, Arensman E, Aromaa E, , ... , Realo A, Reisch T, Schmidtke A, Pérez Sola V, Wittenburg L, Hegerl U (2009). Gender issues in suicide rates, trends and methods among youths aged 15-24 in 15 European countries. J Affect Disord, 113(1-3), 216-226.
     
  104. Hegerl U, Wittenburg L, Gottlebe K, Arensmann E, van Audenhove C, Bouleau JH, van der Feltz-Cornelis CM, Giupponi G, Gusmao R, Kopp M, Marusic A, Maxwell M, Meise U, Oskarsson H, Pull C, Schmidtke A, (2009). Focus on mental health care reforms in Europe: the European alliance against depression: a multilevel approach to the prevention of suicidal behavior. Psychiatr Serv, 60(5), 596-599.
     
  105. Hegerl U, Mergl R, Bottner AC, Holtschmidt-Täschner B, Born C, Seemüller F, Scheunemann W, Henkel V, Angst J (2009). Geschwindigkeit des Depressionsbeginns: Ein Merkmal zur Differenzierung uni- und bipolarer affektiver Störungen. Nervenheilkunde, 28(4), 202-204.
     
  106. Hegerl U, Wittenburg L, Arensman E, Van Audenhove C, Coyne JC, McDaid D, van der Feltz-Cornelis CM, Gusmao R, Kopp M, Maxwell M, Meise U, Roskar S, Sarchiapone M, Schmidtke A, Varnik A, Bramesfeld A (2009). Optimizing suicide prevention programs and their implementation in Europe (OSPI Europe): an evidence-based multi-level approach. BMC Public Health, 9, 428.
     
  107. Förstl H, Werheid K, Ulm K, Schönknecht P, Schmidt R, Pantel J, Horr R, Gutzmann H, Gertz HJ, Frölich L, Bickel H (2009). [MCI-plus: mild cognitive impairment with rapid progression] Dtsch Med Wochenschr, 134(3), 88-91.
     
  108. Förstl H, Bickel H, Frölich L, Gertz HJ, Gutzmann H, Hörr R, Pantel J, Schmidt R, Schönknecht P, Ulm K, Werheid K (2009). [MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy] Dtsch Med Wochenschr, 134(1-2), 39-44.
     
  109. Kornhuber J, Schmidtke K, Frolich L, Perneczky R, Wolf S, Hampel H, Jessen F, Heuser I, Peters O, Weih M, Jahn H, Luckhaus C, Hull M, Gertz HJ, Schroder J, Pantel J, Rienhoff O, Seuchter SA, Ruther E, (2009). Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dement Geriatr Cogn Disord, 27(5), 404-417.
     
  110. Forstl H, Bickel H, Frolich L, Gertz HJ, Gutzmann H, Horr R, Pantel J, Schmidt R, Schonknecht P, Ulm K, Werheid K (2009). [MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy] Dtsch Med Wochenschr, 134(1-2), 39-44.
     


    111. 2008


  111. Forstl H, Bickel H, Frölich L, Gertz HJ, Kurz A, Marksteiner J, Monsch AU, Pantel J, Schmidt R, Schönknecht P (2008). [Mild cognitive impairment with predictors of rapid decline] Dtsch Med Wochenschr, 133(9), 431-436.
     
  112. Hegerl U, Bottner AC, Mergl R, Holtschmidt-Taschner B, Seemüller F, Scheunemann W, Schütze M, Grunze H, Henkel V, Angst J, Born C (2008). [Speed of onset of depressive episodes: a clinical criterion helpful for separating uni- from bipolar affective disorders.] Neuropsychiatr, 22(2), 92-99.
     
  113. Hegerl U, Bottner AC, Holtschmidt-Täschner B, Born C, Seemüller F, Scheunemann W, Schütze M, Grunze H, Henkel V, Mergl R, Angst J (2008). Onset of depressive episodes is faster in patients with bipolar versus unipolar depressive disorder: evidence from a retrospective comparative study. J Clin Psychiatry, 69(7), 1075-1080.
     
  114. Quentin W, König HH, Schmidt JO, Kalk A (2008). Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing. Trop Med Int Health, 13(10), 1245-1256.
     
  115. Schmidt-Recla A, Steinberg H (2008). ["As we're not willing to hang and behead and not able to deport...". On Emil Kraepelin's influence on Franz von Liszt] Nervenarzt, 79(3), 295-304.
     
  116. Karch S, Jäger L, Karamatskos E, Graz C, Stammel A, Flatz W, Lutz J, Holtschmidt-Täschner B, Genius J, Leicht G, Pogarell O, Born C, Moller HJ, Hegerl U, Reiser M, Soyka M, Mulert C (2008). Influence of trait anxiety on inhibitory control in alcohol-dependent patients: simultaneous acquisition of ERPs and BOLD responses. J Psychiatr Res, 42(9), 734-745.
     
  117. Hegerl U, Bottner AC, Mergl R, Blume A, Holtschmidt-Täschner B, Seemüller F, Grunze H, Henkel V, Angst J, Born C (2008). Geschwindigkeit des Depressionsbeginns: Ein Merkmal zur Unterscheidung zwischen uni- und bipolaren affektiven Störungen. In: Marneros A, Röttig D, Biogenese und Psychogenese. (S. 187-197), Regensburg: Roderer Verlag.
     


    118. 2007


  118. Althaus D, Niklewski G, Schmidtke A, Hegerl U (2007). [Changes in the frequency of suicidal behaviour after a 2-year intervention campaign.] Nervenarzt, 78(3), 272-282.
     
  119. Steinberg H, Schmidt-Recla A, Schmideler S (2007). Forensic psychiatry in nineteenth-century saxony: the case of woyzeck. Harv Rev Psychiatry, 15(4), 169-180.
     
  120. Schmidt-Recla A, Steinberg H (2007). Eine publizistische Debatte als Geburtsstunde des "Marburger Programms". Zeitschrift für die gesamte Strafrechtswissenschaft, 119(2), 195-213.
     
  121. Karch S, Graz C, Jager L, Karamatskos E, Flatz AS, Lutz J, Holtschmidt-Taschner B, Genius J, Reiser GL, Moller HJ, Hegerl U, Soyka M, Mulert C (2007). Influence of anxiety on electrophysiological correlates of response inhibition capacities in alcoholism. Clin EEG Neurosci, 38(2), 89-95.
     


    122. 2006


  122. Hegerl U, Althaus D, Schmidtke A, Niklewski G (2006). The alliance against depression: 2-year evaluation of a community-based intervention to reduce suicidality. Psychol Med, 36, 1225-1233.
     


    123. 2005


  123. Schmidt CK, Angermeyer MC, Riedel-Heller SG (2005). Prevention -- a topic in social-psychiatric research? Psychiatr Prax, 32(7), 358-362.
     
  124. Power M, Quinn K, Schmidt S, WHOQOL-OLD Group (2005). Development of the WHOQOL-Old Module. Qual Life Res, 14, 2197-2214.